Abbott Labs (ABT) PT Raised to $145 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Abbott Labs (ABT) PT Raised to $134 at Raymond James
October 21, 2021 7:21 AM EDTRaymond James analyst Jayson Bedford raised the price target on Abbott Labs (NYSE: ABT) to $134.00 (from $128.00) while maintaining a Outperform rating.... More
Abbott Labs (ABT) PT Raised to $141 at Citi
October 21, 2021 5:43 AM EDTCiti analyst Joanna Wuensch raised the price target on Abbott Labs (NYSE: ABT) to $141.00 (from $140.00) while maintaining a Buy rating.... More
Abbott Labs (ABT) PT Raised to $146 at Morgan Stanley
October 21, 2021 4:36 AM EDTMorgan Stanley analyst Cecilia Furlong raised the price target on Abbott Labs (NYSE: ABT) to $146.00 (from $136.00) while maintaining a Overweight rating.... More
Abbott Labs (ABT) PT Raised to $143 at BTIG, Following Earnings
October 20, 2021 2:27 PM EDTBTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $143.00 (from $136.00) while maintaining a Buy rating.
... MoreAbbott raises annual earnings outlook as COVID-19 test sales rebound
October 20, 2021 7:36 AM EDTBy Mrinalika Roy and Carl O'Donnell
(Reuters) - Abbott Laboratories said demand for its COVID-19 tests, especially rapid testing, rebounded as the U.S. wrestled with surging coronavirus cases during the quarter, prompting the company to raise its earnings forecast for the year.
The medical device maker's shares rose 3.5% to $123.53 on Wednesday after it also reported third-quarter earnings above analysts' estimates.
The company said it shipped more than 225 million COVID-19 tests globally in... More
Abbott (ABT) Tops Q3 EPS by 47c, Sales Beat
October 20, 2021 7:32 AM EDTAbbott (NYSE: ABT) reported Q3 EPS of $1.40, $0.47 better than the analyst estimate of $0.93. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $9.44 billion.
GUIDANCE:
Abbott sees FY2021 EPS of $5.00-$5.10, versus the consensus of $4.45.
For earnings history and earnings-related data on Abbott (ABT) click here.
... More